Paul Greengard

Molecular Biology · 2000–2010

A researcher in the Science corpus: 16 papers; trusts 1 researcher and is trusted by 21 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 70 citations into it; #3,275 of 17,773 by trust here, #2,304 by citations
• Genetics — 6 citations into it

Whom Paul Greengard trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. P. Cohen

Who trusts Paul Greengard overall

1. Edward Taub
2. Gitendra Uswatte
3. J. Beaulieu
4. J. Shepherd
5. Jeremy K. Seamans
6. Thomas Elbert
7. Yangling Mu
8. P. Pacher
9. Richard L. Huganir
10. J. Day

Papers from Paul Greengard's perspective

Ordered by how strongly the researchers Paul Greengard trusts endorse each paper. Same corpus, a different order for every researcher.

1. The specificities of protein kinase inhibitors: an update. (Biochemical Journal)
2. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. (Cell)
3. "Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells (Science)
4. Embryo-derived stem cells: of mice and men. (Annual Review of Cell and Developmental Biology)
5. A role for Wnt signalling in self-renewal of haematopoietic stem cells (Nature)
6. Wnt proteins are lipid-modified and can act as stem cell growth factors
7. The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. (Cell)
8. Caught up in a Wnt storm: Wnt signaling in cancer. (Biochimica et Biophysica Acta)
9. The Promise and Perils of Wnt Signaling Through β-Catenin (Science)
10. Signal Transduction and the Control of Gene Expression (Science)

Their papers

• Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor (2004) — 2,217 citations
• Application of BACarray for comparative analysis of CNS cell types (2008) — 896 citations
• The neurobiology of slow synaptic transmission. (2001) — 914 citations
• Regulation of NMDA receptor trafficking by amyloid-β (2005) — 1,634 citations
• Essential Role of the Histone Methyltransferase G9a in Cocaine-induced Plasticity (2010) — 648 citations
• Development of a BACarray translational profiling approach for the molecular characterization of CNS cell types (2008) — 1,118 citations
• Pharmacological inhibitors of glycogen synthase kinase 3. (2004) — 608 citations
• DARPP-32: an integrator of neurotransmission. (2004) — 723 citations
• Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. (2002) — 767 citations
• Dichotomous Dopaminergic Control of Striatal Synaptic Plasticity (2008) — 1,202 citations
• Diverse Psychotomimetics Act Through a Common Signaling Pathway (2003) — 296 citations
• GSK-3-selective inhibitors derived from Tyrian purple indirubins. (2003) — 820 citations
• Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesia (2003) — 823 citations
• Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors? (2001) — 635 citations
• Intraneuronal Aβ42 Accumulation in Human Brain (2000) — 907 citations
• Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. (2000) — 1,358 citations